Pentobarbital versus medetomidine-ketamine-fentanyl anaesthesia: effects on haemodynamics and the incidence of ischaemia-induced ventricular fibrillation in swine.
The present study was performed to compare haemodynamic variables at baseline and the incidence of ventricular fibrillation during the early phase of ischaemia in swine during pentobarbital or medetomidine-ketamine-fentanyl anaesthesia. Twenty-two swine (mean +/- SD: 29+/- 3 kg) were anaesthetized with sodium pentobarbital (induction with 36 mg/kg intraperitoneally, and maintenance with 5-20 mg/kg/h intravenously [i.v.]) and 6 swine (27+/- 3 kg) were anaesthetized with ketamine and fentanyl (premedicated with medetomidine 0.1 mg/kg and ketamine 10 mg/kg intramuscularly, induction with ketamine 20 mg/kg and fentanyl 0.025 mg/kg i.v., and maintenance with ketamine 20 mg/kg/h and fentanyl 0.025 mg/kg/h i.v.). After a stabilization period of 30 min, the left anterior descending coronary artery (LAD) was occluded for 10 min. Haemodynamic data and occurrence of ventricular fibrillation were recorded. The ischaemic area was measured by fluorescing microspheres. Swine anaesthetized with medetomidine-ketamine-fentanyl had significantly lower heart rate, myocardial contractility, peak left ventricular pressure, arterial blood pressure, aortic blood flow, myocardial blood flow and cardiac index at baseline, than swine anaesthetized with pentobarbital. Whereas none of the swine anaesthetized with pentobarbital fibrillated during the LAD occlusion, ventricular fibrillation occurred in 83% of the animals anaesthetized with medetomidine-ketamine-fentanyl (P< 0.001). No significant difference was found in size of ischaemic area between the two groups. Thus, we show a depression in haemodynamic variables at baseline and a higher incidence of ventricular fibrillation during the early phase of ischaemia in swine anaesthetized with medetomidine-ketamine-fentanyl compared to swine anaesthetized with pentobarbital.
Institute for Experimental Medical Research, University of Oslo, Oslo, Norway. frank.grund@c2i.net
F
F
Grund
O
O
Tjomsland
I
I
Sjaastad
A
A
Ilebekk
K A
KA
Kirkebøen
D000758:Anesthesia / Q000009:adverse effects* / Q000662:veterinary*; D000777:Anesthetics / Q000009:adverse effects*; D000818:Animals; D003250:Constriction; D003331:Coronary Vessels; D005260:Female; D005283:Fentanyl / Q000009:adverse effects; D006439:Hemodynamics / Q000187:drug effects*; D007511:Ischemia / Q000150:complications; D007649:Ketamine / Q000009:adverse effects; D008297:Male; D020926:Medetomidine / Q000009:adverse effects; D010424:Pentobarbital / Q000009:adverse effects; D013552:Swine; D013553:Swine Diseases / Q000139:chemically induced*; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000662:veterinary*
D000777:Anesthetics; D007649:Ketamine; D010424:Pentobarbital; D020926:Medetomidine; D005283:Fentanyl